AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spire Healthcare Group PLC

Remuneration Information Mar 28, 2018

5328_dirs_2018-03-28_350028f4-f2b9-430a-9daa-29b973d96354.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2648J

Spire Healthcare Group PLC

28 March 2018

28 March 2018

Spire Healthcare Group plc

Grant of 2018 Long Term Incentive Plan awards

Spire Healthcare Group plc (the "Company") announces that, on 28 March 2018, a performance share award (the "Award") was granted over the Company's ordinary shares in the form of nil cost options to the following Executive Director in the Company, under the rules of the Spire Healthcare Group plc Long Term Incentive Plan.

Name                         Maximum number of shares under Award

Justin Ash                  576,058

The number of shares set out above is the maximum number which may vest under the Award following the cessation of the performance period. The actual number of shares which vest will depend on the extent to which the following performance conditions have been satisfied.

The performance conditions applicable to the Award will be based as follows:

·    35% on relative total shareholder return (TSR) performance;

·    35% on adjusted earnings per share (EPS) performance; and

·    30% on two Operational Excellence measures.

Furher details of these performance conditions will be disclosed in the 2017 Directors' Remuneration Report which will be published in April.

The share price used to determine the number of shares under the Award was £2.1352 being the average of the middle market quotation over the last five dealing days ending on 27 March 2018.

The transaction place is London.

Name of contact and telephone number for queries:

Philip Davies                                                 020 7427 9092

Deputy Company Secretary

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

a) Name Justin Ash
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1 pence each

GB00BNLPYF73
b) Nature of the transaction Grant of performance share awards under the Company's Long Term Incentive Plan
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 576,058
d) Aggregated information

- Aggregated volume

- Price
As above
e) Date of the transaction 2018-03-28
f) Place of the transaction XLON

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBBGDXDSDBGII

Talk to a Data Expert

Have a question? We'll get back to you promptly.